For breast, more care, less pain

Breast cancer, the enemy of healthy women

Q: trends in breast cancer incidence of this disease is like?

A: 120 million women worldwide each year suffer from breast cancer and 500,000 women die from this cancer. North America, Western Europe is the high incidence of breast cancer, the incidence of the United States about 10 million people in 110.4 patient. In China, the incidence of breast cancer to a rate of 3% per year, some cities in economically developed breast cancer incidence has risen to the first female cancer, the incidence of breast cancer in women in Shanghai has reached 10 million About 50 patients.

Q: What are the early symptoms of breast cancer? How to detect and treat?

A: Compared with other malignancies, due to the growth of breast cancer is the organ in the human superficial tumors, easy to be found early, therefore regular screening every year can not be omitted, especially after a 30-year-old woman or a high risk of breast cancer.

The current data show that breast self-examination can reduce breast cancer mortality, through regular breast ultrasound photos and molybdenum to early detection of breast cancer, early treatment, thereby reducing breast cancer recurrence and mortality.

Breast cancer, who favored

Q: What kind of people susceptible to breast cancer? Breast cancer patients affected by genetic great?

A: age of first pregnancy more than 30 years of age and nulliparous women, women for women; eating too much animal fat, overweight postmenopausal women; risk of certain chronic breast disease (such as atypical ductal hyperplasia, papillary like Liu Bing, etc.); menarche before the age of 12 years of age or before menopause in women 55 years of age are more susceptible to breast cancer. Long-term use of estrogen to control menopausal symptoms in women, the risk of breast cancer many years will increase.

In addition, family history of cancer, especially his parents or sister had breast cancer patients, the possibility of breast cancer than other people's congress about 30%.

Breast cancer, where the trap

Q: hyperplasia of breast cancer will be converted into, right?

A: Mammary hyperplasia and degradation are the physiological changes in women of childbearing age cyclical phenomenon, in which very few atypical hyperplasia associated with increased 2 to 3 times the risk of breast cancer; not associated with atypical hyperplasia will not increase the risk of breast cancer risk.

Q: childbirth and breastfeeding and breast cancer related to it?

A: single women, or older than 40 years old unmarried, not pregnant or of childbearing age first child more than 30 years of age, the incidence of breast cancer was significantly higher than normal marriage and childbearing women. First child before the age of 25 full-term producer, the incidence rate of breast after the first child for the 30-year-old full-term producer of 1 / 3. Although the birth, but not breast-feeding, or breast-feeding time is short, or only one side of the breast with breast-feeding women may also be the occurrence of breast cancer patients will have an impact. Therefore, the right of women after childbirth breast feeding can maintain patency, the incidence of breast cancer patients have a preventive effect. Rarely or never breast-feeding, such as breastfeeding. The risk of breast cancer increased significantly.

Q: using breast products will lead to breast cancer?

A: If you use the Breast products containing estrogen, it may increase the risk of breast cancer.

Q: breast plump women is higher than estrogen, and that they are also susceptible to breast cancer?

A: There is no evidence of breast fullness and the level of estrogen. However, if the breast fullness, then small lesions within the breast is not easy to find, so we must be checked regularly.

Experience of breast cancer, how do we break through

Q: Which of the commonly used breast cancer treatment?

A: Currently, treatment of breast cancer has made substantial progress, surgery, radiotherapy, chemotherapy, endocrine therapy has been tied into the efficacy of treatment of breast cancer does have four means.

In recent years has also been a targeted therapy drug, has brought to cancer patients new hope. Conventional chemotherapy in the inhibition of tumor cell killing, when is also toxic to normal cells, it is not selective. However, different targeted therapy, it is more targeted, more selective, it can replace the expansion of cancer genes, to kill breast cancer recurrence and metastasis likely pathogenic strain, almost no damage to normal cells, can effectively improve the treatment outcome the patient's adverse reaction is very small, therefore, is a good way to overcome cancer.

Q: Recently the European Commission approved the trastuzumab treatment of early HER2-positive breast cancer, the application of the drug in our country about how effective?

A: HER2 is a cross the cell membrane of human epidermal growth factor receptor proto-oncogene, as its structure, reproduction rate, or expression level changes, may have carcinogenic effects. In human breast cancer, about 20% to 30% showed overexpression of HER2, HER2 overexpressing breast cancer to conventional chemotherapy programs (such as CMF and other drugs) is not sensitive, and may be resistant to tamoxifen. Anti-HER2 targeted therapy Herceptin as a drug, significantly inhibited tumor cell proliferation. In the clinical setting, Herceptin as adjuvant therapy to directly reduce tumor metastasis and recurrence, and further extend the survival of patients with breast cancer. Currently, Herceptin has been listed in China, despite its expensive, but no other drugs of its advantages can be replaced by clinicians and patients of all ages.

Q: breast cancer surgery and postoperative chemotherapy, the cost of how much the general?

A: The cost of breast cancer surgery is 2 million. However, the cost of the comprehensive treatment and breast cancer staging. Treated by surgery alone in early breast cancer can be, and the cost of chemotherapy for advanced breast cancer is different from the total cost of a few thousand dollars to several million have chemotherapy. In short, the emphasis on individual treatment.

Q: How old is generally the incidence of breast cancer? Young women may be sick it? Incidence of Chinese women and foreign What is the difference?

A: peak incidence of breast cancer in different Western countries and China, only one peak of incidence in Western countries, breast cancer incidence increases with age increased; In China there are two incidence peaks, one is 40 to 50 years old, the other 60 years of age. In this age of older women to maintain a higher vigilance. Especially in late postmenopausal women, menopause was postponed for one year breast cancer risk increased by 50%. Young women suffering from breast cancer, while not high, but often develop rapidly, it can not be taken lightly.

TIPS: trastuzumab (Herceptin) of small files

Trastuzumab (Herceptin) is an HER2 monoclonal antibody combination can accurately identify the expression of HER2 in tumor cells through inhibition of the body or kill a variety of tumor cells. The drug was approved in 1998 by the U.S. FDA for the treatment of breast cancer, in combination with chemotherapy after surgery or alone to prevent breast cancer recurrence or spread.

North America for HER2-positive breast cancer, two clinical degree of experience, patients receiving doxorubicin and cyclophosphamide chemotherapy in a year's time, Herceptin combined with chemotherapy group and the simplistic Duo group, breast cancer reduce the risk of recurrence by 52%, 33% lower risk of death.